This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. plummeted 30.3% to $7.91 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.2% to 26,656.18 and the Dow Jones Industrial Average falling 0.2% to 50,461.68.
This was the stock's second consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 61.5% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 0.5% to $6.22, Fortress Biotech Inc. fell 1.8% to $2.69, and Viking Therapeutics Inc. fell 0.29% to $30.80.
Trading volume totaled 3.7 million, compared to the 50-day average of 272,674.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 26, 2026 16:33 ET (20:33 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments